Literature DB >> 27694678

UK and Twenty Comparable Countries GDP-Expenditure-on-Health 1980-2013: The Historic and Continued Low Priority of UK Health-Related Expenditure.

Andrew J E Harding1, Colin Pritchard1.   

Abstract

It is well-established that for a considerable period the United Kingdom has spent proportionally less of its gross domestic product (GDP) on health-related services than almost any other comparable country. Average European spending on health (as a % of GDP) in the period 1980 to 2013 has been 19% higher than the United Kingdom, indicating that comparable countries give far greater fiscal priority to its health services, irrespective of its actual fiscal value or configuration. While the UK National Health Service (NHS) is a comparatively lean healthcare system, it is often regarded to be at a 'crisis' point on account of low levels of funding. Indeed, many state that currently the NHS has a sizeable funding gap, in part due to its recently reduced GDP devoted to health but mainly the challenges around increases in longevity, expectation and new medical costs. The right level of health funding is a political value judgement. As the data in this paper outline, if the UK 'afforded' the same proportional level of funding as the mean average European country, total expenditure would currently increase by one-fifth.
© 2016 by Kerman University of Medical Sciences.

Entities:  

Keywords:  Healthcare Expenditure; International Comparison.; UK gross domestic product (GDP)

Mesh:

Year:  2016        PMID: 27694678      PMCID: PMC5010654          DOI: 10.15171/ijhpm.2016.93

Source DB:  PubMed          Journal:  Int J Health Policy Manag        ISSN: 2322-5939


  9 in total

1.  How the NHS measures up to other health systems.

Authors:  David Ingleby; Martin McKee; Philipa Mladovsky; Bernd Rechel
Journal:  BMJ       Date:  2012-02-22

2.  Towards a politics of health.

Authors:  Clare Bambra; Debbie Fox; Alex Scott-Samuel
Journal:  Health Promot Int       Date:  2005-02-18       Impact factor: 2.483

3.  Expensive cancer drugs: a comparison between the United States and the United Kingdom.

Authors:  Ruth R Faden; Kalipso Chalkidou; John Appleby; Hugh R Waters; Jonathon P Leider
Journal:  Milbank Q       Date:  2009-12       Impact factor: 4.911

4.  Funding the NHS. Is the NHS underfunded?

Authors:  J Dixon; A Harrison; B New
Journal:  BMJ       Date:  1997-01-04

5.  Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.

Authors:  L Jönsson; N Justo; A Musayev; A Krishna; T Burke; J Pellissier; I Judson; A Staddon; J Y Blay
Journal:  Eur J Cancer Care (Engl)       Date:  2015-04-28       Impact factor: 2.520

6.  Comparing the USA, UK and 17 Western countries' efficiency and effectiveness in reducing mortality.

Authors:  Colin Pritchard; Mark S Wallace
Journal:  JRSM Short Rep       Date:  2011-07-20

7.  Comparing cancer mortality and GDP health expenditure in England and Wales with other major developed countries from 1979 to 2006.

Authors:  C Pritchard; T Hickish
Journal:  Br J Cancer       Date:  2011-10-04       Impact factor: 7.640

Review 8.  Patient choice for older people in english NHS primary care: theory and practice.

Authors:  Andrew J E Harding; Frances Sanders; Antonieta Medina Lara; Edwin R van Teijlingen; Cate Wood; Di Galpin; Sue Baron; Sam Crowe; Sheetal Sharma
Journal:  ISRN Family Med       Date:  2014-03-04

9.  Comparing UK and 20 Western countries' efficiency in reducing adult (55-74) cancer and total mortality rates 1989-2010: Cause for cautious celebration? A population-based study.

Authors:  Colin Pritchard; Tamas Hickish; Emily Rosenorn-Lanng; Mark Wallace
Journal:  JRSM Open       Date:  2016-06-06
  9 in total
  3 in total

1.  Cancer-related outcomes in kidney allograft recipients in England versus New York State: a comparative population-cohort analysis between 2003 and 2013.

Authors:  Francesca Jackson-Spence; Holly Gillott; Sanna Tahir; Jay Nath; Jemma Mytton; Felicity Evison; Adnan Sharif
Journal:  Cancer Med       Date:  2017-01-30       Impact factor: 4.452

2.  Mortality in the USA, the UK and Other Western Countries, 1989-2015: What Is Wrong With the US?

Authors:  Colin Pritchard; Sam Porters; Emily Rosenorn-Lanng; Richard Williams
Journal:  Int J Health Serv       Date:  2020-10-15       Impact factor: 1.663

3.  National Health Systems and COVID-19 Death Toll Doubling Time.

Authors:  Miguel Alfaro; Diego Muñoz-Godoy; Manuel Vargas; Guillermo Fuertes; Claudia Duran; Rodrigo Ternero; Jorge Sabattin; Sebastian Gutierrez; Natalia Karstegl
Journal:  Front Public Health       Date:  2021-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.